Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02504645
Brief Title: A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus (LUPUZOR)

First Submitted : July 17, 2015
First Submitted that Met QC Criteria : July 21, 2015
First Posted : July 22, 2015 (Estimate)

Results First Submitted : February 12, 2019
Results First Submitted that Met QC Criteria : April 10, 2019
Results First Posted : April 11, 2019

Last Update Submitted that Met QC Criteria : April 10, 2019
Last Update Posted : April 11, 2019